X
Time to fix pharma’s outdated business model
https://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/janssen-kris-sterkens-pharma-business-model/
payers
Lilly collaborating with digital firm in ‘real world’ diabetes studies
Rivals Novo Nordisk, Sanofi, and AstraZeneca also offering digital health services.
OECD calls for ‘rebalancing of power’ in drug price negotiations
Health systems should fund more treatments for chronic diseases, says EFPIA